These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13076048)

  • 21. [Results of therapeutic tests of instinctive-affective reequilibration: test therapy of manic excitation syndromes with certain ergot derivatives (hydrogenated alkaloids, hydergin)].
    ABELY P; ABDOUCHELLI A; BEUCHER M; FOURMENT J
    Ann Med Psychol (Paris); 1952 May; 110(1 5):595-9. PubMed ID: 14944039
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with the use of alkanolamides of lysergic acid in clinical obstetrics].
    WOLLMANN H
    Z Geburtshilfe Gynakol; 1950; 134(1):109-23. PubMed ID: 14810077
    [No Abstract]   [Full Text] [Related]  

  • 23. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical research on the oxytocic action of hydroxybutylamide of lysergic acid (partergin)].
    PELLIZZARI C
    G Sci Mediche; 1950 Apr; 5(4):76-9. PubMed ID: 14773862
    [No Abstract]   [Full Text] [Related]  

  • 25. The excessive use of ergot.
    BLUMENTHAL LS; FUCHS M
    Am Pract Dig Treat; 1959 Sep; 10():1502-6. PubMed ID: 13801747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Circulatory effects of new ergot alkaloids on humans].
    BLUNTSCHLI HJ; GOETZ RH
    Schweiz Med Wochenschr; 1947 Jul; 77(29):769-71. PubMed ID: 20258099
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental psychotic states.
    MACDONALD JM; GALVIN JA
    Am J Psychiatry; 1956 Jun; 112(12):970-6. PubMed ID: 13313809
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical assays of ergot and ergot fluidextract.
    STRONG JW; MAURINA FA
    J Am Pharm Assoc Am Pharm Assoc; 1953 Jul; 42(7):414-20. PubMed ID: 13069336
    [No Abstract]   [Full Text] [Related]  

  • 29. Dissociation constants of some compounds related to lysergic acid. II. Ergometrine, ergometrinine and alkanolamides of 3-dimethylaminopropionic acid, 1-methylhexahydronicotinic acid and arecaidine.
    CHILTON J; STENLAKE JB
    J Pharm Pharmacol; 1962 Jun; 14():367-70. PubMed ID: 13878985
    [No Abstract]   [Full Text] [Related]  

  • 30. The hydrogenated alkaloids of ergot (hydergine) in geriatrics; follow-up study.
    POPKIN RJ
    Am Pract Dig Treat; 1956 Oct; 7(10):1594-7. PubMed ID: 13362833
    [No Abstract]   [Full Text] [Related]  

  • 31. INCREASE IN ANTI-5HT ACTIVITY BY L-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS.
    YUI T; TAKEO Y
    Jpn J Pharmacol; 1964 Mar; 14():107-8. PubMed ID: 14167727
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory production of ergot alkaloids by species of balansia.
    Bacon CW; Porter JK; Robbins JD
    J Gen Microbiol; 1979 Jul; 113(1):119-26. PubMed ID: 501329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hydrogenated alkaloids of ergot in mental and nervous disorders associated with old age.
    HOLLISTER LE
    Dis Nerv Syst; 1955 Sep; 16(9):259-62. PubMed ID: 13251096
    [No Abstract]   [Full Text] [Related]  

  • 34. The history and present-day use of ergot.
    MOIR JC
    Can Med Assoc J; 1955 May; 72(10):727-34. PubMed ID: 14364431
    [No Abstract]   [Full Text] [Related]  

  • 35. PHARMACOLOGY of ergot.
    Res Today; 1946; 3(3):59-65. PubMed ID: 20274569
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stabilization of the ergot fluid extract Ph. H. V].
    SIEGFRIED B; SCHNEIDER R
    Pharm Acta Helv; 1953 Jun; 28(6):169-77. PubMed ID: 13100000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental and clinical study on the association of a fraction of Veratrum viride with a derivative of ergot of rye].
    AGUAYO A; GRANIER M; HORANDE M
    Gac Med Caracas; 1956; 64(1-2):81-6. PubMed ID: 13365825
    [No Abstract]   [Full Text] [Related]  

  • 38. [PRIMARY DYSMENORRHEA. TRIAL TREATMENT WITH A DERIVATIVE OF RYE ERGOT].
    CHABRIER J; BARRIER J
    Rev Fr Gynecol Obstet; 1964; 59():345-53. PubMed ID: 14169676
    [No Abstract]   [Full Text] [Related]  

  • 39. A new artificial ergot derivative, dehydroergotamine (DHE45).
    KOPPANYI T
    Anat Rec; 1946 Dec; 96(4):584. PubMed ID: 20282327
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.